Proteomics identification and characterization of MbovP730 as a potential DIVA antigen of Mycoplasma bovis

The human blood DNA methylome identifies crucial role of β-catenin in the pathogenesis of Kawasaki disease

Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis

Tumor-derived granzyme B-expressing neutrophils acquire antitumor potential after lipid A treatment

MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases

MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4

Cancer-related transcription regulator protein NAC1 forms a protein complex with CARM1 for ovarian cancer progression

Comparative molecular characterization of typical and exceptional responders in glioblastoma

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo

Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis

Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells

Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib

Efficacy of a new cancer treatment strategy based on eradication of tumor-initiating stem cells in a mouse model of Krebs-2 solid adenocarcinoma

A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells

Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells

Prostate cancer susceptibility gene HIST1H1A is a modulator of androgen receptor signaling and epithelial to mesenchymal transition

Targeting of BMI-1 expression by the novel small molecule PTC596 in mantle cell lymphoma

Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer

2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck

The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma

Thymoquinone challenges UHRF1 to commit auto-ubiquitination: a key event for apoptosis induction in cancer cells

P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer

RIOK1 kinase activity is required for cell survival irrespective of MTAP status

Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model

Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry

Role for the transcriptional activator ZRF1 in early metastatic events in breast cancer progression and endocrine resistance

Advantage of HSP110 (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients

Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus

Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer

Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1

Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients

Induction chemotherapy reduces extracellular heat shock protein 72 levels, inflammation, lipoperoxidation and changes insulin sensitivity in children and adolescents newly diagnosed with acute lymphoblastic leukemia

Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment

Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations